Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood bilirubin amount,,RS:0004633,SD-Fhem1+/+,male,0 days,3,,CMO:0000047,plasma indirect bilirubin level,,,,0.4,umol/l,0.0577,0.1,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104949,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood bilirubin amount,,RS:0004633,SD-Fhem1+/+,female,0 days,3,,CMO:0000047,plasma indirect bilirubin level,,,,0.1,umol/l,0.1155,0.2,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104950,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood bilirubin amount,,RS:0004632,SD-Fhem1+/-,male,0 days,3,,CMO:0000047,plasma indirect bilirubin level,,,,-0.6,umol/l,0.1155,0.2,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104951,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood bilirubin amount,,RS:0004632,SD-Fhem1+/-,female,0 days,3,,CMO:0000047,plasma indirect bilirubin level,,,,-0.2,umol/l,0.1732,0.3,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104952,control condition